Humira One Year Out: The Largest LOE Event In US Pharma History
Amgen’s Amjevita Biosimilar Set To Launch On 31 January 2023 With Many More To Follow
Ahead of the first biosimilar Humira product set to launch in less than a year, In Vivo provides a comprehensive run-down of where biosimilar sponsors stand and the key issues ahead of market formation.
